This program provides practical information for for participants to be able to initiate an SGLT2i for their heart failure patients and incorporate therapy in an optimal timeframe.
Accreditation Statement
In accordance with ACCME policy, prior to participating in this activity, you must review the information on this page.
Joint AccreditationIn support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit StatementPhysicians
The ACCF designates this MOD for a maximum of up to 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.While offering the CME credits noted above, this program is not intended to provide extensive training or certification in the field.
MOC Information
Successful completion of this CME/CNE/MOC activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
NursesThe ACCF designates this educational activity for a maximum of 1.5 continuing nursing education contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Pharmacists
ACCF designates this continuing education activity for 1.5 contact hours 1.5 CEUs of the Accreditation Council for Pharmacy Education.
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
While offering credits noted above, the course is not intended to provide extensive training or certification in this field.
Target Audience:
CV team clinicians including physicians, nurse practitioners, physician assistants and pharmacists who manage patients with heart failure.
Important Dates:Date of Release: April 4, 2022Term of Approval/Date of Expiration: April 4, 2023Learner Objectives: Upon completion of this activity, you should be able to:
Acknowledgements:Educational grant support provided by: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.To request credit, you must:
This CME/CNE/MOC-certified activity may contain links to other educational resources such as clinical trial summaries, journal articles, guidelines, etc., that may not be CME-certified. Please note that clicking on the links provided to view these resources will open new windows, which are outside of this CME/CNE/MOC-certified activity.
Faculty:
Alison Bailey, MD, FACCJames L. Januzzi, MD, FACCNosheen Reza, MD, FACCShashank Sinha, MD, FACCMuthiah Vaduganathan, MD, FACC
Peer Reviewer:
Alison Bailey, MD, FACC
Learner ObjectivesUpon completion of this program, you should be able to: